These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 23349733

  • 1. Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial.
    Miyagawa T, Kawamura H, Obuchi M, Ikesaki A, Ozaki A, Tokunaga K, Inoue Y, Honda M.
    PLoS One; 2013; 8(1):e53707. PubMed ID: 23349733
    [Abstract] [Full Text] [Related]

  • 2. Abnormally low serum acylcarnitine levels in narcolepsy patients.
    Miyagawa T, Miyadera H, Tanaka S, Kawashima M, Shimada M, Honda Y, Tokunaga K, Honda M.
    Sleep; 2011 Mar 01; 34(3):349-53A. PubMed ID: 21358852
    [Abstract] [Full Text] [Related]

  • 3. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials.
    Meskill GJ, Davis CW, Zarycranski D, Doliba M, Schwartz JC, Dayno JM.
    CNS Drugs; 2022 Jan 01; 36(1):61-69. PubMed ID: 34935103
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy.
    Szabo ST, Hopkins SC, Lew R, Loebel A, Roth T, Koblan KS.
    Sleep Med; 2023 Jul 01; 107():202-211. PubMed ID: 37209427
    [Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
    Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF.
    Neurology; 1997 Aug 01; 49(2):444-51. PubMed ID: 9270575
    [Abstract] [Full Text] [Related]

  • 6. Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials.
    Watson NF, Davis CW, Zarycranski D, Vaughn B, Dayno JM, Dauvilliers Y, Schwartz JC.
    CNS Drugs; 2021 Dec 01; 35(12):1303-1315. PubMed ID: 34822113
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of polygenic risks for narcolepsy and essential hypersomnia.
    Yamasaki M, Miyagawa T, Toyoda H, Khor SS, Liu X, Kuwabara H, Kano Y, Shimada T, Sugiyama T, Nishida H, Sugaya N, Tochigi M, Otowa T, Okazaki Y, Kaiya H, Kawamura Y, Miyashita A, Kuwano R, Kasai K, Tanii H, Sasaki T, Honda Y, Honda M, Tokunaga K.
    J Hum Genet; 2016 Oct 01; 61(10):873-878. PubMed ID: 27305985
    [Abstract] [Full Text] [Related]

  • 8. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.
    Lammers GJ, Arends J, Declerck AC, Ferrari MD, Schouwink G, Troost J.
    Sleep; 1993 Apr 01; 16(3):216-20. PubMed ID: 8506453
    [Abstract] [Full Text] [Related]

  • 9. Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
    Dauvilliers Y, Shapiro C, Mayer G, Lammers GJ, Emsellem H, Plazzi G, Chen D, Carter LP, Lee L, Black J, Thorpy MJ.
    CNS Drugs; 2020 Jul 01; 34(7):773-784. PubMed ID: 32588401
    [Abstract] [Full Text] [Related]

  • 10. Impact of L-carnitine in narcolepsy treatment: a systematic review on the effectiveness and safety.
    Salles C, Freitas MC, Cruz MME.
    Sleep Sci; 2022 Jul 01; 15(Spec 1):278-284. PubMed ID: 35273778
    [Abstract] [Full Text] [Related]

  • 11. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
    Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding CL, Lecomte JM, Schwartz JC, HARMONY I study group.
    Lancet Neurol; 2013 Nov 01; 12(11):1068-75. PubMed ID: 24107292
    [Abstract] [Full Text] [Related]

  • 12. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    Lancet Child Adolesc Health; 2018 Jul 01; 2(7):483-494. PubMed ID: 30169321
    [Abstract] [Full Text] [Related]

  • 13. Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy.
    Bogan RK, Feldman N, Emsellem HA, Rosenberg R, Lu Y, Bream G, Khayrallah M, Lankford DA.
    Sleep Med; 2015 Sep 01; 16(9):1102-8. PubMed ID: 26298786
    [Abstract] [Full Text] [Related]

  • 14. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 01; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy.
    Miyagawa T, Kawashima M, Nishida N, Ohashi J, Kimura R, Fujimoto A, Shimada M, Morishita S, Shigeta T, Lin L, Hong SC, Faraco J, Shin YK, Jeong JH, Okazaki Y, Tsuji S, Honda M, Honda Y, Mignot E, Tokunaga K.
    Nat Genet; 2008 Nov 01; 40(11):1324-8. PubMed ID: 18820697
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 20. Selegiline in the treatment of narcolepsy.
    Hublin C, Partinen M, Heinonen EH, Puukka P, Salmi T.
    Neurology; 1994 Nov 01; 44(11):2095-101. PubMed ID: 7969965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.